Akero Therapeutics, Inc.

Q2 2021 13F Holders

Symbol
AKRO
CUSIP
00973Y108
Type
Equity
Class
COM
Num filings
101
Total reported value, excl. options
$701 M
Manager Report Date Value ($000) Shares Option Type